Erratum: Stem cell-ness: A "magic marker" for cancer (Journal of Clinical Investigation (2005) 115 (1463-1467) DOI: 10.1172/JCI25455);Stem cell-ness: A "magic marker" for cancer

Journal of Clinical Investigation

Volumn 115, Issue 6, 2005, Pages 1463-1467

  Lahad, John P ^a   Mills, Gordon B ^a   Coombes, Kevin R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

BMI 1 GENE; BUB1 GENE; CANCER; CANCER GROWTH; CCNB1 GENE; CES1 GENE; CES3 GENE; FGGR2 GENE; GBX2 GENE; GENE; GENE EXPRESSION; GENE REPLICATION; GENETIC ANALYSIS; HCFC1 GENE; HUMAN; KI67 GENE; KNTC2 GENE; MARKER GENE; MK167 GENE; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNF2 GENE; STEM CELL; USP22 GENE;

EID: 20444462349     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI25455E1     Document Type: Erratum

References (28)

1. Glinsky, G.V., Berezovska, O., and Glinskii, A.B. 2005. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115:1503-1521. doi:10.1172/JCI23412.
2. Michiels, S., Koscielny, S., and Hill, C. 2005. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 365:488-492.
3. Ransohoff, D.F. 2004. Rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev Cancer. 4:309-314.
4. Ransohoff, D.F. 2005. Lessons from controversy: ovarian cancer screening and serum proteomics. J. Natl. Cancer. Inst. 97:315-319.
5. Cheng, W., Liu, J., Yoshida, H., Rosen, D., and Naora, H. 2005. Lineage infedility of epithelial ovarian cancers is controlled by HOX genes char specify regional identity in the reproductive tract. Nat. Med. 11:531-537.
6. Dick, J.E. 2003. Breast cancer stem cells revealed. Proc. Natl. Acad Sci. U. S. A. 100:3547-3549.
7. Park, I.K., et al. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:302-305.
8. Lessard, J., and Sauvageau, G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255-260.
9. Itahana, K., et al. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23:389-401.
10. Molofsky, A.V., et al. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:962-967.
11. Jacobs, J.J., et al. 1999. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:2678-2690.
12. Cahill, D.P., et al. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:300-303.
13. Hanks, S., et al. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUBIB. Nat. Genet. 36:1159-1161.
14. Gao, A.C., Lou, W., and Isaacs, J.T. 2000. Enhanced GBX2 expression stimulates growth of human prostate cancer cells via transcriptional up-regulation of the interleukin 6 gene. Clin. Cancer Res. 6:493-497.
15. Igarashi, T., et al. 2004. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod. Pathol. 17:1259-1267.
16. Dubrez, L., et al. 2001. Cell cycle arrest is sufficient for p53-mediated tumor regression. Gene Ther. 8:1705-1712.
17. Moffa, A.B., Tannheimer, S.L., and Ethier, S.P. 2004. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol. Cancer Res. 2:643-652.
18. Chen, C., et al. 2005. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene. doi:10.1038/sj.onc.1208497.
19. Sanchez-Beato, M., et al. 2004. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J. Pathol. 204:528-537.
20. Hayashi, T., and Su, T.P. 2001. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc. Natl. Acad. Sci. U. S. A. 98:491-496.
21. Kretschmer, T., et al. 2002. Painful neuromas: a potential role for a structural transmembrane protein, ankyrin G. J. Neurosurg. 97:1424-1431.
22. Redinbo, M.R., Bencharit, S., and Potter, P.M. 2003. Human carboxylesterase I: from drug metabolism to drug discovery. Biochem. Soc. Trans. 31:620-624.
23. Marsh, S., et al. 2004. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics. 84:661-668.
24. Gentleman, R. 2005. Reproducible research: a bioinformatics case study. Statistical Applications in Genetics and Molecular Biology [serial online]. 4:Article 2. http://www.bepress.com/sagmb/vol4/iss1/art2.
25. Gentleman, R., and Lang, D.T. 2004. Statistical Analyses and Reproducible Research. Bioconductor Project Working Papers [serial online]. Working Paper 2. http://mvw.bepress.com/bioconductor/paper2.
26. Leisch, F., and Rossini, A. 2003. Reproducible statistical research. Chance. 16:46-50.
27. Bhattacharjee, A., et al. 2001. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 98:13790-13795.
28. Ioannidis, J.P. 2005. Microarrays and molecular research: noise discovery? Lancet. 365:454-455.